The Impact Of Male Circumcision And Penile Modification Practices On Women In Papua New Guinea, Including Women's Risk Of HIV Transmission.
Funder
National Health and Medical Research Council
Funding Amount
$95,313.00
Summary
This grounded theory study will investigate the impact of male circumcision and penile modification practices on women in PNG, including women�s risk of HIV. The study aims to describe women�s understanding and experience of male circumcision and penile modifications and the processes they use to manage the outcomes of male circumcision. Implications for national HIV policy in Papua New Guinea will be identified. This study will be supported by researchers in Papua New Guinea and Australia.
Longitudinal Clinical And Qualitative Research To Inform National Policy On HIV/STI Prevention And Sexual Health In Melanesia
Funder
National Health and Medical Research Council
Funding Amount
$332,123.00
Summary
This research will investigate the epidemiology and socio-cultural context of HIV, sexually transmitted infections and determinants of sexual health among men and women in Papua New Guinea, Solomon Islands and Vanuatu. This work will enable stakeholders and policy-makers to gain an in-depth understanding of behavioural and other correlates of sexual risk in selected population cohorts and will inform the development of robust, locally-appropriate sexual health and HIV/STI prevention strategies.
IMPROVING PULMONARY TUBERCULOSIS (TB) OUTCOMES: Investigating Novel Adjunctive Immunotherapies And Addressing HIV-TB Co-infection In Papua, Indonesia
Funder
National Health and Medical Research Council
Funding Amount
$217,846.00
Summary
Tuberculosis remains a major regional and global problem, especially in resource-limited settings such as Australia’s northern neighbours. Three key challenges are to make TB cure easier by shortening treatment, improve HIV-TB co-infection management, and tackle drug resistance. We address these issues in Indonesia’s Papua Province, where we are testing whether simple supplements given with TB treatment might accelerate cure; improving HIV care in people with TB, and detecting drug-resistant TB.